跳至主要内容
临床试验/NCT04935840
NCT04935840进行中(未招募)不适用

Clinical Study to Evaluate the Effect of a Food Supplement With Probiotics on the Metabolic Profile of Pregnant Women

Fertypharm2 个研究点 分布在 1 个国家目标入组 84 人开始时间: 2021年5月5日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
84
试验地点
2
主要终点
Glucose homeostasis

研究概览

简要总结

The aim of this study is determine the effect of a food supplement with probiotics on metabolic profile and weight gain in pregnant women.

详细描述

After being informed about the study, all patients meeting the inclusion/exclusion criteria and giving written informed consent all patients will be treated with the food supplement that contain vitamins, minerals and probiotics. All volunteers will receive one capsule per day of the food supplement throughout the study. The duration of the supplementation will be from their inclusion in the study (≤ 14 weeks of gestation) until the 30th-32nd week of pregnancy, the time of the end-of-study visit.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None (Participant, Investigator)

入排标准

年龄范围
35 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Pregnant women
  • Age: > 18 years old
  • BMI > 25
  • Women who have signed the informed consent to participate in the study.
  • No intention to change their routine physical activity or usual dietary intakes throughout the study

排除标准

  • > 14 weeks' gestation
  • Taking food supplements or probiotics
  • History or current pathology that influence in the study
  • With major fetal abnormalities
  • Had used continuous antibiotic therapy for at least 3 months

结局指标

主要结局

Glucose homeostasis

时间窗: 30-32 weeks gestation

Glucose homeostasis status will be evaluated by measuring fasting glucose

次要结局

  • Insulin levels(30-32 weeks gestation)
  • Weight gain(30-32 weeks gestation)
  • Insulin resistance(30-32 weeks gestation)
  • Lipid concentration(30-32 weeks gestation)

研究者

发起方
Fertypharm
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验